GLP-1 injections, also known as Glucagon-like peptide-1 receptor agonists, are a type of medication that we utilize in our medical practice to target the symptoms of type 2 diabetes
For people trying to start or continue taking GLP-1 RA medication, access issues are incredibly distressing, especially because GLP-1 RAs are meant to be taken regularly and long-term
More serious potential adverse effects include pancreatitis, gallbladder disease (cholelithiasis, cholecystitis), acute kidney injury (especially with dehydration), and increased risk of hypoglycemia when used with insulin or sulfonylureas
Respondents had an average age of 42.6 years and were 54.4% female, 45.1% male, and 0.5% nonbinary, representing all 50 states and the District of Columbia
Signs that you should hold include persistent nausea lasting more than seven days after a dose escalation, vomiting more than twice per week, diarrhea requiring dietary modification, or appetite suppression severe enough to prevent adequate protein intake
P., Engstrom, T
